## Answer
First, let's understand what extracellular vesicles (EVs) are. EVs are small particles released by cells that can carry various molecules such as proteins, lipids, and nucleic acids. They play a role in cell-to-cell communication and have been implicated in various physiological and pathological processes, including cardiovascular diseases.

The patient in question has a history of gradually increasing blood pressure, which is indicative of hypertension. Hypertension is associated with endothelial dysfunction, which is characterized by a decrease in the bioavailability of vasodilators, such as nitric oxide, and an increase in vasoconstrictors. This imbalance leads to an overall increase in vascular tone, contributing to high blood pressure.

Now, let's analyze the options:

A. EVs do influence vascular tone, so this option is incorrect.

B. While EVs from hypertensive patients may carry molecules that contribute to vasoconstriction, it's not accurate to say they directly cause vasoconstriction. So, this option is also incorrect.

C. Similarly, it's not accurate to say that EVs from normotensive patients directly cause vasodilation. So, this option is incorrect.

D. This option suggests that EVs from the hypertensive patient would reduce acetylcholine-induced vasodilation compared to EVs from a normotensive individual. This is plausible because acetylcholine is a molecule that induces vasodilation, and in the context of hypertension and endothelial dysfunction, the response to acetylcholine would be impaired.

E. The destruction of EVs from this patient would not necessarily reduce acetylcholine-induced vasodilation. In fact, if these EVs are contributing to the impaired vasodilation seen in hypertension, their destruction might improve the response to acetylcholine. So, this option is incorrect.

Therefore, the answer is D. EVs from this patient will reduce acetylcholine-induced vasodilation as compared with EVs from a normotensive individual.